GSK Investigational Site

Clamart 92141

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Insomnia, Obstetric Labour, Premature, Sleep Initiation and Maintenance Disorders

Studies at this site

• Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma — Completed
• The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor — Completed
• Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia — Completed